Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1

Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1 The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)).
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Direct Response Marketer Banned A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements. Direct Response Marketer Banned A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA. FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA. FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury. FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury. NNFA Files Health Claims Comments NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting. NNFA Files Health Claims Comments NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting. Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.	The November 19, 2005 publication of the Canada Gazette, Part 1 (Vol. 139, No. 47 — November 19, 2005 - http://canadagazette.gc.ca/partI/2005/20051119/html/regle1-e.html ) contained good news and progress for the natural health products industry as the process of legislative renewal at last got to the contentious issue of whether companies should be allowed to make claims for products targeted at the list of diseases noted in 'Schedule A'. The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)). Section 3 of the Food and Drugs Act prohibits the advertising of any food, drug, cosmetic or device to the general public as a treatment, preventative or cure for any of the diseases, disorders or abnormal physical states referred to in Schedule A. It also prohibits the sale to the general public of any food, drug, cosmetic or device that is labelled as a treatment, preventative or cure for any of the diseases, disorders or abnormal physical states referred to in Schedule A. The actual proposed changes to the wording of the Natural Health Products Regulations read: 5. The Regulations are amended by adding the following after section 103.1: Prohibited Advertising 103.2 A natural health product is exempt from subsection 3(1) of the Act with respect to its advertisement to the general public as a treatment or preventative for any of the diseases, disorders or abnormal physical states referred to in Schedule A to the Act. Prohibited Label or Advertisement Where Sale Made 103.3 A natural health product is exempt from subsection 3(2) of the Act with respect to its sale by a person where the natural health product is represented by label or is advertised by that person to the general public as a treatment or preventative for any of the diseases, disorders or abnormal physical states referred to in Schedule A to the Act.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software